Fesoterodine Fumarate Tablet, Extended Release
Product Images NDC 43598-247

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Fesoterodine Fumarate (NDC 43598-247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container4mg (Container4mg)

FDA Label Image

Container8mg (Container8mg)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

This is a graph that represents the change in urge incontinence episodes per 24 hours in Study 1, over the course of 12 weeks. The data consists of 211 participants and the graph shows a gradual decrease in the number of incontinence episodes over time. There is no additional information available from the text.*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

The text is describing a figure showing the change in urge incontinence episodes per 24 hours over the course of 12 weeks, with measurements taken at weeks 0, 2, 8, and 12. The study included 205 participants and is referred to as "Study 2". The mean change from baseline is being reported.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.